Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., et al. (2021). Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide. CA: A Cancer Journal for Clinicians, 71, 209–249.
PubMed
Google Scholar
Marur, S., Forastiere, A. A., Westra, W. H., Chung, C. H., Shrime, M. G., Cohen, R. B., et al. (2016). Head and neck squamous cell carcinoma: Update on epidemiology, diagnosis, and treatment. Mayo Clinic Proceedings, 91, 386–396.
Article
PubMed
Google Scholar
Hanna, G. J., Woo, S. B., Li, K. K., Barletta, J. A., Hammerman, P. S., Lorch, J. H., et al. (2017). Locoregional management of head and neck cancer: Past, present, and future. Journal of Clinical Oncology, 35, 661–669.
Google Scholar
De Felice, F., Musio, D., Tombolini, V., De Vincentiis, M., Trotti, A., Valentini, V., et al. (2020). Follow-up in head and neck cancer: A management dilemma. Advances in Therapy, 37, 467–477.
Google Scholar
Alix-Panabières, C., Pantel, K., Bidard, F. C., Smerage, J., Hayes, D. F., Tewes, M., et al. (2021). Liquid biopsy: From discovery to clinical application. Cancer Discovery, 11, 858–873.
Article
PubMed
Google Scholar
van Ginkel, J. H., Huibers, M. M. H., Noorlag, R., de Bree, R., Willems, S. M., Heideman, D. A. M., et al. (2021). Monitoring treatment response using ctDNA in patients with locally advanced head and neck cancer. Clinical Cancer Research, 27, 3986–3994.
Google Scholar
Kulasinghe, A., Perry, C., Warkiani, M. E., Blick, T., Davies, A., O’Byrne, K., et al. (2021). Circulating tumour cells in head and neck cancers: Current insights and future perspectives. Cancers, 13, 1095.
Google Scholar
Jatana, K. R., Balasubramanian, P., Lang, J. C., Yang, L., Jatana, K. R., Chalmers, J. J., et al. (2022). Prognostic value of circulating tumour cells in head and neck cancer. JAMA Otolaryngology. Head & Neck Surgery, 148, 1136–1144.
Google Scholar
Kang, Z., Li, Y., Zhang, X., Li, L., Zhao, H., Wang, Y., et al. (2022). Clinical significance of circulating tumour DNA in human and neck cancer: A systematic review and meta-analysis. Oral Oncology, 130, 105893.
Google Scholar
Ashworth, T. (1869). A case of cancer in which cells similar to those in the tumour were seen in the blood after death. The Medical Journal of Australia, 14, 146–147.
Google Scholar
Alix-Panabières, C., Pantel, K., Schwarzenbach, H., Riethdorf, S., Rack, B., Tewes, M., et al. (2014). Circulating tumour cells: Liquid biopsy for cancer monitoring. Cancer Discovery, 4, 313–326.
Google Scholar
Bidard, F. C., Peeters, D. J., Fehm, T., Nolé, F., Gisbert-Criado, R., Mavroudis, D., et al. (2018). Prognostic value of circulating tumour cells in breast cancer patients: Prediction of metastatic relapse. Cancer Research, 78, 4125–4134.
Google Scholar
Reed, J., McAllister, S. S., Gascard, P., Bissell, M. J., Park, M., Tsai, K. K., et al. (2020). The role of circulating tumour cells in cancer prognosis and monitoring using liquid biopsy. Cancer Biology & Therapy, 21, 1–11.
Google Scholar
Müller Bark, J., Le Rhun, E., Preusser, M., Roth, P., & Weller, M. (2020). Circulating biomarkers in patients with glioblastoma. British Journal of Cancer, 122, 295–305.
Article
PubMed
Google Scholar
Zhou, J., Kulasinghe, A., Bogseth, A., O’Byrne, K., Punyadeera, C., & Papautsky, I. (2019). Isolation of circulating tumor cells in non-small-cell lung cancer patients using a multi-flow microfluidic channel. Microsystems & Nanoengineering, 5, 8.
Article
Google Scholar
Schmidt, H., Kulasinghe, A., Perry, C., Nelson, C., & Punyadeera, C. (2016). A liquid biopsy for head and neck cancers. Expert Review of Molecular Diagnostics, 16, 165–172.
Article
CAS
PubMed
Google Scholar
Kulasinghe, A., Kapeleris, J., Kimberley, R., Mattarollo, S. R., Thompson, E. W., Thiery, J. P., et al. (2019). Phenotypic characterization of circulating lung cancer cells for clinically actionable targets. Cancers (Basel), 11, 380.
Article
CAS
PubMed
Google Scholar
Kapeleris, J., Kulasinghe, A., Warkiani, M. E., Vela, I., Kenny, L., O’Byrne, K., et al. (2020). Ex vivo culture of circulating tumour cells derived from non-small cell lung cancer. Translational Lung Cancer research, 9, 1795–1805.
Article
CAS
PubMed
PubMed Central
Google Scholar
Feng, Q., Liu, J., Wang, H., Sun, W., Song, Y., Wang, Y., et al. (2021). Molecular characterization of circulating tumour cells and their role in tumour biology. Oncogene, 40, 689–700.
Google Scholar
Zhang, X., Chen, T., Yu, L., Yang, S., Xu, M., Li, W., et al. (2024). Circulating tumour cells predict recurrences and survival in head and neck squamous cell carcinoma patients. Cellular and Molecular Life Sciences, 81, 233.
Article
CAS
PubMed
PubMed Central
Google Scholar
Zhang, X., Yu, L., Chen, T., Yang, S., Li, W., Xu, M., et al. (2022). Application of circulating tumour cells to predict response to treatment in head and neck cancer. Cellular Oncology, 45, 543–555.
Article
CAS
PubMed
Google Scholar
Nieto, M. A., Huang, R. Y. J., Jackson, R. A., & Thiery, J. P. (2016). Mechanisms of epithelial-mesenchymal transition in cancer. Trends in Cell Biology, 26, 1–16.
Google Scholar
Massagué, J. (2012). TGFβ signaling in cancer. Nature Reviews. Cancer,12, 39–52.
He, W., Zhong, G., Jiang, N., Wang, B., Fan, X., Chen, C., et al. (2017). Wnt/β-catenin pathway and its implications in epithelial-mesenchymal transition and cancer metastasis. Cellular and Molecular Life Sciences, 74, 657–668.
Google Scholar
Miele, L., Golde, T., & Osborne, B. (2006). Notch signaling in cancer metastasis: Regulation and therapeutic implications. Journal of Clinical Investigation, 116, 1234–1242.
Google Scholar
Cao, M., Xu, J., Liu, Z., Li, H., Sun, B., Wang, C., et al. (2020). The role of EGFR and FGF in regulating EMT pathways in cancer cells. Journal of Cell Biology, 209, 237–245.
Google Scholar
Kalluri, R., & Weinberg, R. A. (2009). The basics of epithelial-mesenchymal transition. Journal of Clinical Investigation, 119, 1420–1428.
Article
CAS
PubMed
PubMed Central
Google Scholar
Lamouille, S., Xu, J., & Derynck, R. (2014). Transcriptional regulation of epithelial-mesenchymal transition during cancer progression. Cancer Research, 74, 3082–3092.
Google Scholar
Brabletz, T., Kalluri, R., Nieto, M. A., & Weinberg, R. A. (2021). EMT and the metastatic progression of cancer. Nature Reviews. Cancer, 21, 1–17.
Google Scholar
Bracken, C. P., Gregory, P. A., Khew-Goodall, Y., & Goodall, G. J. (2008). Regulation of the ZEB1/miR-200 feedback loop in metastasis and epithelial-mesenchymal transition. Oncogene, 27, 2277–2289.
Google Scholar
Jiang, Y., Li, Y., & Zhu, B. (2015). Role of TWIST1 in promoting epithelial-mesenchymal transition and metastasis in circulating tumour cells. Cancer Research, 75, 1323–1335.
Google Scholar
Pastushenko, I., & Blanpain, C. (2019). EMT: Hybrid epithelial/mesenchymal states in cancer metastasis. Developmental Cell, 49, 1–14.
Google Scholar
Jolly, M. K., Celia-Terrassa, T., & Levine, H. (2015). Intermediate or hybrid epithelial-mesenchymal states in cancer metastasis and their increased metastatic potential. Journal of Cell Science, 128, 2285–2297.
Google Scholar
Xu, J., Lamouille, S., & Derynck, R. (2015). EMT spectrum and its role in cancer progression. Cellular and Molecular Life Sciences, 72, 4015–4031.
Google Scholar
Kessenbrock, K., Plaks, V., & Werb, Z. (2010). Matrix metalloproteinases: Regulators of the tumor microenvironment. Cell, 141, 52–67.
Article
CAS
PubMed
PubMed Central
Google Scholar
Dongre, A., & Weinberg, R. A. (2019). New insights into the role of immune checkpoints and apoptosis resistance in circulating tumour cells. Molecular Oncology, 13, 455–463.
Google Scholar
Rankin, E. B., & Giaccia, A. J. (2016). Hypoxic control of metastasis. Science, 352, 175–180.
Article
CAS
PubMed
PubMed Central
Google Scholar
Xie, F., Zhou, X., Fang, M., Li, H., Su, P., Tu, Y., et al. (2020). Hypoxia-induced epithelial–mesenchymal transition in cancer: Implications for CTC generation and metastasis. Cancer Letters, 487, 66–72.
Google Scholar
Semenza, G. L. (2012). Hypoxia-inducible factors in physiology and medicine. Cell, 148, 399–408.
Article
CAS
PubMed
PubMed Central
Google Scholar
Jiang, Y., Liu, H., Li, Y., Zhou, W., Chen, J., Lin, Y., et al. (2020). Hypoxia-induced epithelial-to-mesenchymal transition and its contribution to circulating tumour cell generation in solid tumours. Journal of Cellular and Molecular Medicine, 24, 1270–1283.
Google Scholar
Gilkes, D. M., Semenza, G. L., & Wirtz, D. (2014). Hypoxia-induced matrix metalloproteinases in cancer cells and their role in metastasis. Cancer Cell, 25, 54–68.
Google Scholar
Rankin, E. B., & Giaccia, A. J. (2016). Hypoxia, HIFs, and their role in promoting metastasis and circulating tumour cells. Trends in Cancer, 2, 107–118.
Google Scholar
D’Errico, A., Ricciardi, M. R., & Sgambato, A. (2017). The role of NRF2 in metabolic adaptation of circulating tumour cells. Cell Death & Disease, 8, Article e2969.
Google Scholar
Ponomarev, A., Sevriukova, O., Galkina, O., Gaponova, T., Smirnova, E., Ivanova, O., et al. (2018). Glycolysis in circulating tumour cells: An adaptive survival mechanism. Journal of Clinical Oncology, 36, 3439–3446.
Google Scholar
LeBleu, V. S., O’Connell, J. T., Gonzalez Herrera, K. N., Wikman, H., Pantel, K., Haigis, M. C., et al. (2014). PGC-1α mediates mitochondrial biogenesis and oxidative phosphorylation to promote metastasis. Nature Cell Biology, 16, 992–1003.
Article
CAS
PubMed
PubMed Central
Google Scholar
Choi, J. H., Oh, A. Y., Kang, M. S., Kwon, H. J., Oh, M. H., Lee, H. J., et al. (2015). Fatty acid oxidation supports tumour cell survival during oxidative stress. Cancer Research, 75, 3251–3261.
Comments (0)